© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
During a four-hour hearing Nov. 14 led by the chairman of the House Energy and Commerce oversight subcommittee, FDA Commissioner Margaret Hamburg was asked if the FDA could have prevented the recent fungal meningitis outbreak.